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1. Abstract
This work investigated single-walled carbon nanotube (SWNT)/polymer-protein A complexes
for optically reporting antibody concentration via a change in near infrared fluorescent
emission after antibody binding. SWNT have potential as biosensors because of extraordinary
sensitivity, lack of photobleaching, and optical activity in a near-infrared window. A SWNT
sensor could provide label-free measurements of antibody concentration in a continuous
fashion, which may aid selection of production strains. Protein A itself, dextran, poly vinyl
alcohol, DNA sequences, and chitosan were used as polymers for wrapping SWNT. Nonspecific
binding to solution-phase constructs was found to be a major problem with these approaches.
Chitosan hydrogels encapsulating SWNT also show nonspecific responses.
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3. Introduction
The goal of my research was to design and synthesize a protein A-polymer/ single-walled
carbon nanotube (SWNT) complex to optically report antibody binding via a change in near
infrared fluorescent emission. This would allow for a SWNT based sensor to rapidly report
antibody concentrations, potentially in real-time.
3.1 Nanotube sensors
SWNT are cyclindrical structures composed entirely of sp2 hybridized carbon atoms. They were
discovered in 1991 by Sumio lijima. Typical nanotubes have a diameter on the order of 1nm and
have been grown as long as 18.5cm(Wang X 2009). Nanotubes differ in their chiral angle, a set
of two numbers (n,m), which defines how a flat sheet of graphene should be rolled up in order
to create the nanotube. There are zigzag (n=0,m=0), chiral (m is not 0 or n), and armchair
(m=n) nanotubes. Armchair nanotubes are metallic while the other species are
semiconducting.
SWNT have been attracting significant attention in research because of many advantageous
optical, electrical, and mechanical characteristics. The one-dimensional electronic structure of
nanotubes creates clear emission peaks in the near infrared (900-1400nm), which can be
altered by interaction of analytes with the nanotube surface (Satishkumar 2007; Zhang,
Boghossian et al. 2011), forming the conceptual basis for a sensor. The dielectric constant of
the media surrounding the nanotube is a key variable influencing the optical transition energy
(Strano 2007), but the local dielectric constant for complicated solutions is not apparent.
Nanotube sensors have the advantages that no photobleaching threshold has been reported
(Saito 1998; Daniel A. Heller 2005) and adsorption of single-molecules to the nanotube sidewall
has been reported (Laurent Cognet 2007; Anni J. Siitonen 2010; Hong Jin 2010). Additionally,
the near infrared wavelengths used for excitation and monitored for emission fall within the
near infrared window in biological systems, where light penetrates tissue relatively well, making
the use of the sensor with a cell culture system a definite possibility (L. R. Hirsch 2003). This
work focused predominantly on probing nanotubes through photoluminescence, where a
photon excites an electron into the valence band, creating an electron-hole pair or exciton. The
exciton generally undergoes nonradiative decay, but sometimes, generally around 1% of the
time, the electron recombines with the hole and a photon is emitted (Sang-Yong Ju 2009). This
process only occurs in semiconducting nanotubes.
The polymer or protein serves the role of keeping the system colloidally stable. SWNT powder
consists of many bundled SWNT held together by strong van der Waals forces, and while the
sonication procedure separates the nanotubes, the polymer or protein attaches to the newly
dispersed nanotubes via hydrophobic interactions(Faiella G 2009).
SWNTs are being investigated as materials for reinforced composites due to their extremely
high Young modulus and tensile strength. For example, some of the first commercial
applications of SWNT include epoxys with carbon nanotubes which boast increased strength
(Amroy 2011). SWNT are also being investigated as promising candidates for miniaturized
electronics because metallic nanotubes behave as excellent conductors which generate much
less heat, even when running high currents, because of their ballistic mode of conduction (Ando
2009; ScienceDaily 2009). These mechanical and electrical characteristics are not exploited in
this work.
The biocompatibility of SWNT is a growing area of research. Cytotoxicity has been shown in
vitro. For example, about 30% of alveolar macrophages died upon exposure to 11.30 Ig/cm 2 of
SWNT dispersed via ultrasonication without a surfactant (Guang Jia 2009). In vivo mice show
dose-dependent oxidative stress, acute inflammation, and fibrosis after pharyngeal aspiration
or exposure to aerosolized as-produced HiPco SWNT. Various measures of inflammation, such
as the numbers of polymorphonuclear leukocytes and alveolar macrophages, are significant at
exposure levels of 5pg/mouse or 5 mg/m 3 for 5 h/day for 4 days (A. A. Shvedova 2008).
Interestingly, pristine SWNT have been shown to be biodegraded by the neutrophil enzyme
human myeloperoxidase, creating shorter non-inflammatory nanotubes (Valerian E. Kagan
2010). While all of these studies suggest that SWNT biocompatibility merits further research,
since the biological applications of SWNT, for either sensing or drug delivery, will use SWNT
suspended in polymers, toxicity studies with the specific SWNT/polymer system will need to be
performed. For example, despite demonstrated toxicity of pristine nanotubes, the Dai lab
showed that PEG suspended SWNT show no toxic side effects after IV injection and was cleared
almost completely after 2 months (Zhuang Liu 2008).
The Strano group has developed many SWNT based fluorescent sensors, including sensors for
the detection of glucose (Paul W. Barone 2009), Nitric oxide(Zhang, Boghossian et al. 2011),
protein-protein interactions(Jin-Ho Ahn 2011), hydrogen peroxide(Hong Jin 2010), and
ATP(Jong-Ho Kim 2010). The expertise accumulated from the development of these successful
systems provided a logical opportunity for development of protein A based antibody sensor. All
of these sensors are based on changes in photoluminescence.
Due to the relatively recent discovery of nanotubes in 1991, nanotubes are not yet a
standardized commodity. There are several nanotube vendors, who all supply slightly different
nanotubes. For example, SouthWest NanoTechnologies' CoMoCat nanotubes are produced by
flowing pure CO at a total pressure between 1 and 10 atm and at a temperature of 700-950*C
over a Cobalt and molybdenum catalyst. There is a hydrogen reduction step after this. Samples
contain over 50% (6,5) nanotubes, as well as a significant number of (7,6) nanotubes
(NanoTechnologies 2011). Nano-C nanotubes are produced by an unknown method with
multiple combustion gases, a catalyst, and a purification step (Nano-C 2011). Nano-C samples
contain many chiralities.
3.2 Antibodies
Antibodies are an extraordinarily versatile class of molecules with which the immune system
combats perpetually evolving threats. Antibodies complexed with antigen trigger complement
activation by binding to C1q, which eventually leads to the formation of membrane attack
complexes. Complexed antibodies will also bind to Fc receptors on leukocytes, which will
trigger different cytotoxic effector functions, such as release of lysosomal enzymes (Hamilton
2001).
Antibodies have 4-18% carbohydrate and are made up of two identical heavy chains, each
~50kDA, and two identical light chains, each ~25kDA, for a total weight of about 150kDA. The
heavy and light chains have disulfide bridges between them. Antibodies are split into IgM, IgD,
IgG, IgE, and IgA classes depending on substantial differences in their heavy chains. The
primary sequences of IgG heavy chains are over 95% identical. The critical variation is in the
hypervariable loops, made up of residues from the heavy and light chains, which creates the
diverse specificity of antibody targets. There are three hypervariable regions present in each of
the two IgG antigen binding arms. The hinge region is also a site of variability. IgG1 is the most
highly concentrated IgG and is generally present at around 10mg/mL in adults. The structure of
an IgGI antibody is seen in Figure 1. Both the antigen binding regions (Fab regions) and the
constant 'crystallizable' region (Fc region) are shown (Hamilton 2001).
Figure 1: A ribbon diagram of an IgG2 anti-canine lymphoma monoclonal antibody. The heavy chains are shown in red and
blue. The light chains are shown in green and yellow. The two bottom bundles of the red and blue chains together
constitute the Fc region. The rest of the protein constitutes the Fab region. The PDB code is 1IGT.
Monoclonal antibodies had aggregate global sales of $38 billion in 2009. The top selling
monoclonal antibodies include cancer targeting antibodies, such as Herceptin and Avastin, and
anti-tumor necrosis alpha antibodies, such as Enbrel and Remicade, which are used for
treatment of rheumatoid arthritis and Crohn's disease. The total market for protein based
therapeutics is expected to show an annual growth rate between 7-15% in the next several
years(Walsh 2010).
Manufacture of monoclonal antibodies was first made possible by hybridoma technology,
which created immortalized antibody producing cells by fusing a B cell with a myeloma cell.
There are now many manufacturing systems, including CHO cells, yeast cells, and even efforts
to create transgenic goats (Kling 2009).
Global antibody sales are impressive, and so are the costs associated with producing
antibodies. Companies advancing antibodies are required by the FDA to have a Master Cell
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Bank (MCB), which is a collection of cells which are meant to provide an identical starting point
for production runs and certified to be free from contamination. For any company developing a
monoclonal antibody there is inevitably a race to get the antibody onto the market as quickly as
possible, in order to maximize the revenues achieved while patent protection still prevents
generic companies from selling an identical product. As an aside, patent expiration may not be
the end of a market monopoly for the innovating company when it comes to antibodies
because no antibody biosimilars have been approved, and there is regulatory uncertainty as to
whether they will be allowed. Different glycoforms, disulfide pairing, deamidation, and
cyclization of N-terminal glutamine residues make antibody manufacturing a particularly tricky
biosimilar manufacturing task (Initiative 2010). Regardless, profit is being lost if product launch
is delayed. The incentive to get the antibody to market quickly may cause companies to begin
testing their antibodies with suboptimal MCB titers. Companies can work on obtaining a more
highly productive MCB in parallel with clinical trials, but additional animal and human testing
may be required to prove that the end product is analytically equivalent (Fenno 2007). A
potential issue is a change in glycosolation, which could trigger an immune response or alter
the antibody mediated cytoxicity (Thommes 2010). There are contract manufacturing
organizations which utilize proprietary techniques in order to boost antibody titer. For
example, Catalent offers 'GPEx technology' which consists of inserting genes coding for the
protein product at multiple genomic locations by RNA retroviruses which cannot replicate, but
carry the protein product genes, reverse transcriptase, and integrase (Catalent 2011).
The quest to establish a stable master cell bank with a high titer is a critical determinant of
product cost. A survey of the economics of monoclonal antibody production called titer 'the
overriding cost driver in producing monoclonal antibodies' (Farid 2007).
In order to boost cell productivity there has been a research focus on increasing gene copy
number and transcriptional rate. Specific efforts include identifying stronger promoters, site
specific integration of DNA, including DNA that prevents heterochromatin repression, use of
Internal Ribosome Entry Sites, and improving folding kinetics through manipulation of BiP, PDI,
and other chaperones (James 2009). Regardless of the particular method of creating a pool of
antibody producing cells with a range of productivity, some strategy must be employed to
identify those that are stable and highly productive cells.
Current methods for selecting highly productive antibody producing cells are reviewed by
Browne et al. and Shukla et al. (Al-Rubeai 2007; Thommes 2010). They include Limited Dilution
Cloning (LDC), Fluorescence activated cell sorting (FACS), gel microdrop technology, and
automated cell selection systems. In LDC single cells are seeded into well plates and then ELISA,
or similar techniques, is used. It is slow and widely used. FACS is high throughput but relies on
the ability to fluorescently tag the produced antibody or a molecule that is presumed to be
linked to the amount of antibody production. For example, GFP can be co-expressed with the
heavy and/or light chains, a surface protein can be co-expressed with the antibody and later
detected with a fluorescent antibody, or fluorescently labeled methotrexate can be added to
cells transfected with a vector which contains dihydrofolate reductase (binding of the
methotrexate to the dihydrofolate reductase acts as a reporting scheme for how many copies
of the vector were integrated into the host genome). The reporting gene is often driven by a
weak promoter, whereas light and heavy chain expression is driven by a strong promoter such
as the cytomegalovirus promoter. These FACS based methods are a drastic improvement over
LDC, but fluorescence may not always correspond to short or long-term productivity (Al-Rubeai
2007; Warren Pilbrough 2009; Ye 2010). Gel microdrops are a technique which immobilizes the
secreted antibodies within a polymer gel and then relies on a series of biotin, avidin, and
antibody interactions to create fluorescence proportional to the immobilized antibody.
Automated cell selection systems use a fluorescently labeled antibody to quantify the amount
of antibody being secreted by a spot of immobilized cells and then select productive spots by
physically picking them (ClonePix, Cellcollector) or by destroying only the less productive spots
with a laser (LEAP). Both gel microdrops and automated cell selection systems require a
detection antibody with a fluorescent label to be designed against the antibody being
produced.
3.3 Rationale for a SWNT-based Antibody Sensor
A SWNT based sensor would have a number of advantages over these technologies: first, no
labeling of the target antibody or cell producing that antibody is required; second, it matches or
exceeds the throughput of the above technologies; third, the productivity of cells can be
monitored almost continuously. These advantages are particularly important in cases where
raising an antibody against the secreted antibody is difficult or if the long-term stability of
expression can be predicted by continuous time measurements.
The latter possibility is a particularly intriguing potential advantage of a sensor which can
probe antibody concentrations at much smaller timescales than is currently possible. Such
measurements might be able to monitor bursts of productivity and relate this to unstable
productivity. In other words, better time resolution of antibody secretion by single cells may
help to identify cells which appear to be high producers only due to bursts caused by temporary
promoter activation versus genuine high producers which benefit from a favorable genomic
change as a result of mutation or vector integration. The snapshots of integrated productivity
provided by LDC, FACS, gel microdrops, and automated cell selection systems do not reveal any
of the potentially important details related to how cells respond to growth and environmental
conditions (Kerry Routenberg Love 2010). Monitoring changes in secretion due to changing
conditions could help optimize fermentations. Pilbrough and co-workers showed that there is
very high intraclonal variation in antibody expression in CHO cells (Warren Pilbrough 2009),
which makes it more critical that genuine high producers can be selected early in the
manufacturing process.
There are other label-free technologies which have the potential to fill the same need as a
SWNT-based sensor. Label free protein detection is reviewed by Ray et al. (Sandipan Ray 2010).
One technique is a nanohole array, which relies on monitoring the refractive index of the
medium on a metal surface through extraordinary optical transmission, which is light
transmission through a periodic array of subwavelength holes which is orders of magnitude
higher than is classically predicted. Each detection spot is ~10Im2, theoretically allowing tens
of thousands of spots on a single chip, and was used to detect anti-GST antibodies with a CCD
camera after immobilization of glutathione S-transferase (Jin Ji 2008). Oblique-incidence
optical reflectivity difference is able to distinguish binding events based on changes in the ratio
of the transverse magnetic and electric modes, and was used to image goat anti-mouse
antibody and other protein-protein interactions on a 2,760 spot microarray (Y.Y. Fei 2008).
Enthalpy arrays, which are nanocalorimeters which electrostatically merge 250nL and then
measure temperature change, have the potential to be miniaturized but were reported to have
a Kd detection limit of only 5pM (Recht MI 2008). Silicon nanowire field effect transistors were
shown by the Lieber group to be capable of detecting ATP binding to the immobilized protein
Abl, but a high-throughput system has not been reported by the group (Wayne U. Wang 2005).
Microcantilevers, where binding of molecules to an immobilized target causes a change in the
resonant frequency of the lever, and interference based techniques, where an optical phase
difference due to mass change is detected, are also reviewed (Sandipan Ray 2010).
In summary, a SWNT based sensor provides an attractive platform for label-free, high-
throughput, and continuous testing of cell productivity, which may help to address confounding
intraclonal expression variation. We envision that the sensor could be incorporated into
microspheres encapsulating clonal populations of cells or embedded in a film, reporting local
antibody concentrations and allowing high-producing cell lines to be identified. Such a sensor
would need to be complemented by assays validating the functionality of the antibody, since
protein A will interact mostly with the heavy chain, regardless of the presence of the light chain.
3.4 Plan for Making a Protein A Sensor
In order to make a sensdr specific to antibodies, we choose to use protein A, because it binds
specifically to a broad spectrum of antibodies. The protein has cleverly evolved in
Staphylococcus to sit on the outside of the bacteria and prevent phagocytosis by binding the
constant region (Fc region) of antibodies (Phillip Peterson 1977). Normally, receptors on the
cells of the immune system will bind to exposed Fc regions of antibodies which have recognized
a foreign antigen and bound to it, but Protein A effectively hides the Fc region from the
immune cells and thereby slows opsonization. Protein A has a signal sequence directing it to
the outside of the cell, five similar antibody binding domains, and a cell wall anchoring
sequence. The antibody binding domains contain three alpha helices each and are
approximately 60 amino acids long(Hober S 2007). In addition to high affinity for the Fc regions
of many antibody isotypes, some affinity for Fab regions has been described(Enrico A Sturaa
2001).
We took two conceptually different approaches to creating this SWNT and protein A based
conjugate capable of signal transduction. In general, the approaches comprised of either 1)
wrapping the SWNT non-covalently with a polymer and then covalently attaching Protein A to
the polymer or 2) suspending the SWNT directly with Protein A. The polymers used were
dextran functionalized with phenoxyl groups, poly vinyl alcohol, DNA sequences, and chitosan.
An idealized sensor is depicted in Figure 2.
hv unquenched hv quenched
Protein A Antibody
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Figure 2: Idealized protein A-polymer/SWNT sensor. Near infrared light is used to show to what degree antibodies are
bound to protein A on the sensor surface. In this case the specific polymer is labeled as cMPD. The sWNT is not to scale
with the proteins.
A sample SWNT/polymer-Protein A synthesis scheme is included in Figure 3. Excitation-
emission profiles of the SWNT/polymer-Protein A complexes were measured to check for a
concentration-dependent response to IgG. The antibodies were selected from
chromatographic studies of protein A which showed which antibodies protein A has affinity for,
which is summarized in Figure 4 (Hober S 2007). A spectral deconvolution program was used to
assess the contribution of each species of nanotube to the excitation-emission spectrum.
Typical concentrations of antibody in assays were in the 0-10OOnM range. If binding is due to
protein A and antibody interaction, we expect to see a characteristic sigmoidal signal versus IgG
concentration response of the SWNT/polymer-Protein A complex, but not observe that
response with the SWNT/polymer complex which lacks Protein A. Effective sensor Kd can be
compared to native protein A-IgG Kd, which indicates to what extent a lowered protein A
affinity, due to surface immobilization on the SWNT, and imperfect quenching upon IgG
binding, is present.
It is important to note that most therapeutic antibodies are human IgG1 antibodies, so they will
be amenable to binding protein A attached to a nanotube (Xiaoling Wang 2009; Carter 2010).
In fact, protein A purification is a standard purification technique used by drug companies
(Thommes 2010).
UH OH 0
OH
0O4 OH 0
1-s
Figure 3: Overview of synthesis of SWNT/cPVA-Protein A complex. The first step is a dialysis of Sc/SWNT with cPVA. The
second step is EDc/NHS coupling of the cPVA to the protein A, which is represented by the protein ribbon diagram.
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Figure 4. Staphylococcus Protein A affinity for Immunoglobulin classes. Adapted from Hober et al. Strong binding is ++,
medium binding is +, negligible binding is -.
4. Materials and Methods
Dialysis of SC/SWNT with Protein A: 3mL of 2wt% SC/SWNT was mixed with Protein A for a
final concentration of 300pg/mL Protein A. This solution was added to a dialysis cartridge
(Pearson). The cartridge was placed in 2L of stirred PBS for 24hr. If necessary, the pH of the 2L
solution was adjusted using diluted HCI or NaOH solutions. The 2L solution was changed at
least once during the procedure.
Aggregated nanotubes were filtered out by centrifuging the final solution for 5 hours at 16000g
in 1.5mL microcentrifuge tubes. Care was taken to remove only the supernatant, leaving a little
liquid so the pellet was not disturbed. Free protein A was filtered out using 100kDA Amicon
filters at 4000 RPM for 2 minutes.
Synthesis of cPVA: 6g of PVA powder was added into 200mL of NMP solution in a round
bottom flask. The temperature was raised to 80'C with vigorous stirring to dissolve the PVA
completely. 0.525g of DMAP and 0.43g of succinic anhydride was added to the solution. After
24 hr, the cPVA was precipitated by adding solution dropwise to 800mL isopropyl alcohol. The
solid cPVA was collected by vacuum filtration. This precipitate was redissolved in 60mL
methanol, reprecipitated, and vacuum filtered again. Finally, the cPVA was dried under vacuum
at room temperature
SWNT/Sodium cholate: A 2wt% sodium cholate aqueous solution was prepared. Nanotubes
were added to achieve a final concentration of 0.5 mg/mL. The mixture was sonicated for 2h at
40% amplitude (~10watts) in an ice bath. The resulting suspension was centrifuged for 4 hr at
30,000 RPM and the supernatant was stored for later use.
SWNT/cPVA: Sodium cholate/SWNT solution was added dropwise to a stirred lOwt% cPVA
aqueous solution. 10 min after addition, the mixture was put into a dialysis tube (MWCO
10,000) and a 24hr dialysis was performed in distilled water.
Synthesis of SWNT/cPVA -Protein A: 0.5mL of cPVA solution was mixed with 125pl 33.4 mg/mL
EDC and 175il 24.2 mg/mL of NHS for 2h. Residual EDC and NHS was removed using spin
dialysis tubes with settings of 50 min and 250 rcf. Protein A was added to achieve a final
concentration of 500Ig/mL and stirred for 2 hrs. Free protein A was removed using a spin
dialysis tube with an appropriate molecular weight cutoff.
Synthesis of carboxymethylated phenoxy dextran (CMPD): 8g of Carboxymethylated dextran
was dissolved in 60 mL of 1N-NaOH solution. 6.65g of 1,2-Epoxy-3-phenoxypropane was added
to the dextran solution at 250C. The resulting mixture was stirred for 10 h at 400C. CMPD was
precipitated with an excess of methanol and then filtered. In order to completely remove other
reagents, CMPD was dissolved in 20 mL water, and then precipitated again with an excess of
methanol. This purification was carried out three times.
Synthesis of Dialyzed SWNT/CMPD: 2.9mL of 2wt% Sodium Cholate/SWNT was mixed with a
weight of CMPD 250 times the weight of SWNT. SWNT weight was determined by UV
absorption at 632 nm. The solution was added to a Pierce dialysis unit with molecular cutoff of
3500. The dialysis was carried out in 2L of stirred water for 24hr with the buffer changed at
least once. The sample was then removed and centrifuged for 90 minutes at 16000g. The
supernatant was stored at 4'C until further use.
Synthesis of Sonicated SWNT/CMPD: 20mg of CM PD, 10mL water, and 10mg of SWNT were
mixed. This solution was sonicated for 10 minutes at 1OW while keeping the sample on ice. The
resulting solution was then centrifuged for 90 minutes at 16000g. The supernatant
(approximately 90% of solution) was kept. The centrifugation was then repeated, keeping only
about ~70% of solution. The supernatant was stored at 4'C until further use.
Synthesis of SWNT/CMPD-Protein A: Protein A was attached to the CMPD through EDC/NHS
chemistry. Briefly, 40pl of EDC (0.176M) and 40ptl of NHS (0.263M) was added to 1mL
CMPD/SWNT. The solution was stirred for 30 minutes at room temperature. Spin dialysis was
then performed for 10 min at 13,000 RPM. Next, Protein A dissolved in 1mL PBS (pH 8) was
added for a final Protein A concentration of 400ptg/mL. This solution was gently stirred at room
temperature for 2 hours. The free protein and polymer was filtered out using a dialysis
membrane of with a cutoff of 100kDA. The final SWNT concentration was measured and
samples were stored at 4'C until further use.
Synthesis of SWNT/PLPEG-COOH: 10g of PLPEG-COOH was added to 10 mL of water, and then
5 mg of SWNT was added. The mixture was sonicated for 20 min at a power of 1OW in an ice
bath. The resulting solution was centrifuged for 3 h at 16,000g and the supernatant was stored.
Synthesis of SWNT/PLPEG-COOH -Protein A Complex: The carboxylic acid of PLPEG-COOH was
coupled to amino groups on Protein A. 1mL of SWNT/PLPEG-COOH at a concentration of
25pg/mL was prepared. This was stirred with EDC-HCI (3.5 iM) and NHS(4,914 lpM) for 1.5 h at
25C. Excess EDC and NHS was removed using a centrifugal filter device (Amicon Ultra-4,
MWCO 10 kDa). The SWNT/PLPEG-COOH-Protein A was resuspended in PBS and recentrifuged
twice. Protein A was then added for a final concentration of 300pag/mL. The solution was
gently stirred for 2 h at 250C and 10 h at 4'C.
Synthesis of DNA/SWNT-Protein A Complex: DNA SWNT were synthesized following Zhang et
al. d(AT) 15 and d(GT) 15NH2 oligonucleotides were obtained from (Integrated DNA Technologies).
Briefly, 2mg/mL Nano-C SWNT with 1mg/mL DNA was mixed in a 0.1 M NaCI solution. The
mixtures were sonicated with a 3 mm probe tip (Cole-parmer) for 10 min at a power of 10 W.
Samples were then centrifuged for 3 hours at 16,000g. Finally, the supernatant was collected.
Suspension of Nanotube with Chitosan: Chitosan (0.25 wt% to water) was dissolved in water
containing 1 vol% acetic acid. 20 mg of nanotube was mixed with 10 mL of the chitosan
solution. The resulting mixture was sonicated for 45 min at 40% amplitude (10 watts) in the ice
bath using a probe-tip sonicator. The SWNT/chitosan solution was centrifuged for 3 h at 16,000
g using a tabletop centrifuge. Only ~70% of the supernatant was removed. The new liquid was
centrifuged for 3 h at 16,000 g and the supernatant was removed in the same manner.
Preparation & Modification of SWNT-Chitosan Array: 375 pl of SWNT/chitosan suspension was
well mixed with 125 pl of 2wt% chitosan in a 1 vol% acetic acid solution. SWNT/chitosan
solutions containing 10-100pg/mL SWNT were used. This solution was cross-linked using 2.8 pl
of 50 vol% glutaraldehyde. 3pl of this solution was spotted on a patterned glass slide (4x6
spots). The cross-linking reaction proceeded in a humidified chamber for 15 h at 250C. The chip
was washed with H20 for 15min, with 0.01 M solution of NaOH for 15min, and again with H20
for 15min. The last water wash was done twice, for a total washing time of one hour. To
introduce carboxylic acid to chitosan, 450 mg of succinic anhydride was dissolved in 45mL of
water and the resulting solution was added to the chip. After the reaction proceeded for 5 h at
250C, the array was washed 4 times with water for one hour. To activate the carboxylic acid on
the array, 863 mg of EDC and 575 mg of NHS were dissolved in 45 mL of water, and then the
resulting solution was added to the array for 2 h at 250C. The array was then washed with
water four times in one hour. Then the chips were left in humidified chambers overnight with a
33 mM solution of NTA in PBS at pH 8.0 spotted on top of each hydrogel. After washing the chip
4 times with water in one hour, 45 mL solution 100mM NiSO 4 was added to the array for 1 h at
250C. The array was then stored in the nickel solution or in water for later analysis.
Spectroscopy and Microscopy: Near-infrared photoluminescence spectra were acquired on a
custom inverted microscope, the Zeiss D.1 Observer. The SWNT are excited by a 785nm laser,
from B&W Tek, and the emission is sent to the Princeton Instruments Acton SpectraPro 2500i
Spectrograph spectrometer and the Intervac MOSIR Camera 350 near infrared camera.
Absorption measurements were taken with a Shimadzu UV-3101 PC UV-VIS-NIR scanning
spectrophotometer.
Spectral Deconvolution: A custom Matlab script was used to deconvolute raw spectra by
minimizing the difference between the raw spectrum and a linear combination of spectra from
nanotube species.
Solution phase nanotube response assay: 200pl aliquots of SWNT/polymer-Protein A complex
were put into a 96-well plate at an approximate concentration of 1mg/L. Antibody solution,
typically 60pl, was then added to each well. Spectra were taken before and 24 hours after
addition of antibody solution in order to quantify quenching. The change in signal due to
dilution of the SWNT complex was subtracted out from the final data. Calculated standard
deviations took into account the variation in the measured control experiments that only
looked at the effect of dilution.
Hydrogel nanotube response assay: A 50x/0.7 Zeiss objective was used to image hydrogels on a
glass slide. A typical experiment was run for approximately 30 minutes with a data point
collected as the integrated emission spectra for every 10 seconds. 20il of PBS was added to
each spot on the hydrogel after it was removed from a storage container. After turning on the
laser and allowing signal stabilization 100mM NiSO 4 was added for a final concentration of
50mM. This served as a control to verify that the known potent SWNT quenching of Ni2, could
be observed. The Nickel was then washed away with PBS, leaving 20pl of PBS on the gel. 20p1l
of 0.5mg/ml His-tag protein A was then added to the gel. After 5 minutes of equilibration the
spot was washed. 20ptl of analyte antibody or control protein was then added. These analytes
included human IgG, mouse IgG, rabbit IgG, guinea pig igG, anti-histag antibody, YPD, and BSA.
Data was collected for at least 5 minutes after analyte addition. Washing steps consisted of
aspiration of liquid from the hydrogel spot, addition of 20pl of PBS, aspiration, and addition of
20pl of fresh PBS. Care was taken to minimize contact with the stage during addition and
washing steps.
Because the gel was found to be sensitive to ions in the buffer, PBS exactly matching
Invitrogen's PBS formulation for antibodies was used. It was composed of 3g of NaCl, 111mg of
KH2PO4, and 582mg of Na2HPO 4 dissolved in 500mL of water.
Histagged EGFP Fluorescence Assay: A white light source was used with a Zeiss AxioCam MRm
imaging camera and a 633nm high-pass filter to illuminate a SWNT/chitosan hydrogel
synthesized on a glass slide. A 50X Objective was used and images were collected using Zeiss
Imaging Solutions AxioVision software with an exposure time of 150ms.
Materials: Two types of SWNT were purchased: CoMoCat 'SWeNT SG 65' from SouthWest
Technologies and Nano-C from the company Nano-C. Protein A, Human IgG, Goat IgG, Rabbit
anti-Mouse IgG, Mouse IgG were purchased from Invitrogen.
Guinea Pig IgG was purchased from Santa Cruz Biotechnology.
Distearoyl-sn-glycero-3-phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000]
(ammonium salt) (PLPEG-COOH) was purchased from Avanti Polar Lipids Inc.
NMP, PVA (Mw 13,000-23,000), DMAP, Succinic anhydride, Sodium cholate, Chitosan (low
molecular weight 448869), NiSO 4 hexahydrate, Acetic acid, Na,Na-bis(carboxymethyl)-L-lysine,
Phosphate Buffered Saline, glutaraldehyde, N-(3-dimethylaminopropyl)-N'-ethylcarbo diimide
hydrochloride (EDC.HCI), N-hydroxysuccinimide (NHS), Sodium hydroxide, Hydrochloric acid,
BSA, anti-histag antibody (H1209), 1,2-Epoxy-3-phenoxypropane, methanol, and isopropyl
alcohol were purchased from Aldrich.
(AT) 15NH2 and (GT) 15 oligonucleotides were purchased from Integrated DNA Technologies.
6X4 spot glass slides were purchased from Tekdon.
5. Experimental Results
5.1 Native Gel
Native gels were used to confirm that Protein A binds to the IgG used in experiments. Both
mouse and human IgG showed binding to protein A, as shown in Figure 5. Figure 6 shows that
Guinea pig and rabbit IgG also show binding.
Figure 5: Native Gel showing that Human IgG and Mouse igG bind Protein A. Lane 1 is a standard. Lane 3 is Protein A alone.
Lane 4 is Mouse IgG alone. Lane 6 is Protein A and Mouse IgG. Lane 7 is Human igG alone. Lane 9 is Human IgG and Protein
A. Lanes 5 and 8 were an attempt to check for binding of SWNT/polymer-protein A to the IgG, but are not readily
distinguishable from lanes 4 and 7, respectively, where only IgG was run. Lane 2 has just the SwNT/polymer-protein A.
Figure 6: Native Gel showing that Guinea Pig IgG and Rabbit IgG bind Protein A. Lane 1 is a standard. Lane 3 is Protein A
alone. Lane 4 is Guinea Pig IgG alone. Lane 6 is Protein A and Guinea Pig igG. Lane 7 is Rabbit IgG alone. Lane 9 is Rabbit
IgG and Protein A. Lanes 5 and 8 were an attempt to check for binding of sWNT/polymer-protein A to the IgG, but are not
readily distinguishable from lanes 4 and 7, respectively, where only igG was run. Lane 2 has just the SWNT/polymer-protein
A.
5.2 Direct Suspension by Dialysis
Protein A suspension was improved at higher pH, as seen in Figure 7. There was highly visible
aggregation for pH 3 and pH 5. Recovery of suspended SWNT after centrifugation was low for
all the samples except for pH 9.5, which shows SWNT concentration close to that of the initial
SC/SWNT suspension used, as seen in Figure 8. Unfortunately, even the SWNT suspensions
prepared at pH 7 or 9.5 were only metastable. The solutions flocculated when they were put
into chitosan for hydrogel preparation, as shown in Figure 9 and aggregated by themselves over
a period of days.
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Figure 7: Nanotube solutions and dialysis cartridges without aggregated nanotubes after dialysis with varying pH.
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Figure 8: Absorption spectrum of SWNT/Protein A samples recovered after dialysis at various pH conditions.
Figure 9: Aggregated nanotubes in chitosan gel after suspension directly with protein A at a high pH.
5.3 Carboxy methyl phenoxy dextran
Evidence that SWNT was successfully functionalized with protein A is shown in Figure 10, which
shows the photoluminescence spectrum before and after protein A functionalization.
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Figure 10: Excitation-emission spectrum with normalized intensity versus wavelength for SWNT/CMPD (black) and
SWNT/CMPD-Protein A (red). The spectral shift and relative intensity shift of some peaks is evidence of functionalization.
A series of sample spectra are shown in Figure 11. In each of the 36 panels the upper blue curve
is an excitation-emission spectrum taken before addition of antibody. Each of the lower red
curves is an excitation-emission spectrum taken after addition of antibody, and the sensor
shows clear quenching in this case.
Figure 11: 36 graphs of near-infrared photoluminescence spectra. All graphs are intensity (a.u.) versus emission wavelength
(nm) with blue curves corresponding to control measurements and red curves corresponding to measurements 24 hours
after Rabbit IgG addition. Antibody concentration increases left to right, and it can be seen that the red spectra have
considerably lower intensity to the right. There is no relation between the rows.
The concentration dependent response of photoluminescence to IgG was probed using mouse
IgG, human IgG, guinea pig IgG, and rabbit IgG. Results for rabbit IgG and human igG are shown
in Figure 12 and Figure 13 respectively. Note that the error bars are approximately the same size
in both graphs, but the averaged response for Human IgG is close to zero for all tested
concentrations.
The fitted curves for each nanotube in Figure 12 are derived from considering the reaction
Ab+SWNT +* SWNTAb. Even at concentrations as low as 1nM of Ab, [Ab]>>[SWNT], because
[SWNT] was around 1OOfM.
d [SWNT Ab]
d[ NT~ = kon [Ab] [SWNT] - kff [SWNTAb]dt
Given that Ab~Abo, an expression for the fractional quenching, y, in the system at equilibrium
as a function of the initial antibody concentration and the apparent sensor Kd is
Figure 12: The protein A-dextran/SWNT quenching response for polyclonal rabbit IgG is graphed for 4 different SWNT
species. The solid line fits the data based on the reaction IgG+SWNT <--> SWNTIgG. The fitted Kd values are in the range
230-43OnM.
Figure 13: The protein A-dextran/SWNT quenching response for polyclonal human IgG is graphed for 8 different SWNT
species. The lines connect consecutive points and are meant to aid the reader in looking for a concentration dependent
trend.
Quenching responses for the SWNT/CMPD construct with and without Protein A are shown in
Figure 14 for IgG from three different species. There is a significantly larger response to Mouse
IgG for the protein A sensor, but the nonspecific interaction of the antibody with the
SWNT/CMPD caused the abandonment of further work with this polymer system.
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Figure 14: Percentage quenching versus PBS after addition of Guinea Pig IgG, Mouse IgG, or Human IgG to SwNT/CMPD-
Protein A(left) or SWNT/CMPD (right).
5.5 cPVA
The cPVA sensor, before and after functionalization with protein A, was tested for a response to
guinea pig IgG, mouse IgG, and Human IgG. The results are shown in Figure 15. There is similar
quenching for guinea pig and human IgG, whereas the quenching for mouse IgG is about double
for the protein A version.
Gu- Pig igGW
Figure 15: Percentage of signal quenched by addition of Guinea Pig igG, Mouse IgG, and Human IgG to SWNT/cPVA-Protein A
(left) and SWNT/cPVA (right). The sensor was made starting with purified (6,5) nanotube.
5.6 DNA
DNA polymers for suspending SWNT were explored first without conjugation of Protein A.
Figure 16 shows the responses of (AT) 15NH2 and (GT) 15 oligonucleotide suspended SWNT to
multiple IgG. There are significant responses for most of the tested IgG. Interestingly, the
response to Human IgG is qualitatively different: there is a decrease in intensity after addition
for the oligonucleotide with adenine but an increase in intensity after addition for the
oligonucleotide with guanine.
Figure 16: Percentage of signal quenched by addition of Guinea Pig IgG, Mouse IgG, and Human IgG to (AT) 15/SWNT (left) and
(GT) 15NH2/SWNT (right). This graph is for the deconvoluted (6,5) nanotube. Other nanotubes show similar quenching.
5.7 PLPEG-COOH
PLPEG-COOH is a carboxylated lipid which was previously shown to suspend nanotubes and
allow for conjugation of functional proteins via NHS/EDC chemistry (Jong-Ho Kim 2010). Figure
17 shows the results of screening the PLPEG-COOH construct with four different antibodies.
Work on this sensor was not continued because of issues with nonspecific interaction which are
not shown here.
Figure 17: Percentage of signal quenched by addition of Guinea Pig lgG, Mouse IgG, Human IgG, and Mouse anti-IgE lgG to
SWNT/PLPEG-COOH-Protein A. This graph is for the deconvoluted (6,5) nanotube. Other nanotubes show similar quenching.
Data is from a single run.
5.8 Chitosan Nickel Hydrogel
Chitosan is a copolymer of p-(1->4)-linked 2-acetamido-2-deoxy-D-glucopyranose and 2-amino-
2-deoxy-D-glucopyranose, and it is generally obtained from deacetylating crustacean
exoskeleton. A common definition of a hydrogel is a 'macromolecular network swollen in water
or biological fluids' (J. Berger 2004).
Chitosan nickel chips were synthesized according to a modified procedure of that previously
published by Jin-Ho et al. (Jin-Ho Ahn 2011). The steps are outlined in Figure 18. The final
product is an array of gels, as seen in Figure 19, which can be assayed for response to lgG and
other proteins.
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Figure 18: synthesis scheme for making the chitosan nickel hydrogel. SwNT/CHI are first spotted on a chip and crosslinked.
After carboxylation, NTA is attached to the chitosan via EDC/NHS chemistry. Nickel is then added. Finally, the histagged
Protein A, shown here in red, is added to the complex. Figure is modified from (n-Ho Ahn 2011)
Figure 19: 50X objective imaging a SWNT/Chitosan-NTA/Ni-Protein A hydrogel. There are 16 separate hydrogels on this chip.
A faint red color from the 785nm laser is visible from the objective.
Significant difficulties were encountered in obtaining an excitation-emission spectrum which
showed the well established quenching behavior caused by Ni2+ ions (Jonathan Brege 2009). It
was found that great care was necessary in order to eliminate glutaraldehyde and succinic
anhydride present after cross-linking and succinylation steps respectively, in order to restore
the Ni2+ quenching observed in the original chitosan suspended SWNT. Another significant
experimental change was the use of SWNT in higher proportion relative to chitosan in the gel.
This increased the starting intensity count and minimized the effect of noise.
A sample real-time data run, where signal from the chitosan hydrogel is collected every 10s, is
shown in Figure 20. This procedure follows that of Reuel et al (a paper from the Strano lab
currently under review). After Ni2+ quenching of the gel is shown, histagged Protein A is added,
causing a dramatic increase which is sustained after washing. There is a similar increase after
addition of human IgG. Simple addition does not cause any response. The final addition is anti-
histag antibody, which consistently shows a response.
Figure 21 shows a calibration curve for SWNT/Chitosan-NTA/Ni-Protein A complex with human
IgG. Each point represents an average of multiple runs like the one in Figure 20. There is a
roughly sigmoidal response with a Kd that appears to be on the order of 1OOnM.
Figure 22 shows a control where histagged EGFP is added instead of histagged Protein A. If the
quenching is due to binding of IgG with protein A, no response, or at least no response with a Kd
similar to that of the for SWNT/Chitosan-NTA/Ni-Protein A complex is expected. However,
there is a clear response of the gel with the hisEGFP to the addition of IgG which is on the same
order of magnitude (10%) as the response of the gel with the hisProtein A.
Figure 23 shows a control where BSA is added to a chitosan hydrogel prepared with the
histagged Protein A. For comparison, at this concentration of BSA, the human IgG calibration
curve shows that human IgG would cause about a 15% response. The BSA response at this
concentration was 7%+3%.
The hydrogel construct was also shown to give a large response upon addition of the yeast
culture media YPD, which contains a diverse set of ions, lipids, carbohydrates and peptides from
yeast extract.
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Figure 20: Sample data run showing emission intensity at 996nm over time with addition of human IgG to the chitosan array
with histagged Protein A. Red points represent addition of Ni, Protein A, 1g/L (6pM) Human IgG, PBS, and anti-histag
Antibody. Green points represent washing steps. Blue points are all other data points. Exposure time is 10s.
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Figure 21: SWNT/Chitosan-NTA/Ni Protein A calibration curve for Human IgG. Quenching is graphed versus the log 0 of the
molar concentration
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Figure 22: Sample control run showing emission intensity at 996nm over time with addition of human IgG to the chitosan
array with histagged EGFP. Red points represent addition of Protein A, and Human IgG. Green points represent washing
steps. Blue points are all other data points. Exposure time is 10s. The nickel addition and washing step is not shown.
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Figure 23: Sample data run showing emission intensity at 996nm over time with addition of human igG to the chitosan array
with histagged Protein A. Red points represent addition of Ni, Protein A, and .001g/L (6nM) Human IgG. Green points
represent washing steps. Blue points are all other data points. Exposure time is 10s.
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Figure 24: Sample data run showing emission intensity at 996nm over time with addition of BSA to the chitosan array with
histagged Protein A. Red points represent addition of Ni, Protein A, and .5g/L (6pM) BSA. Green points represent washing
steps. Blue points are all other data points. Exposure time is 10s.
Figure 25 shows histagged EGFP fluorescence after a series of washing steps. It appears that no
additional fluorescence is retained on the gel with the NTA/Ni compared to the gel with only
NTA. This was an unexpected result, and indicates that either the NTA group is not being
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attached to the chitosan during the synthesis or there is so little of it that the EGFP retained by
binding to NTA/Ni cannot be resolved over the fluorescence attributable to nonspecific binding.
Figure 25: Histagged EGFP fluorescence from chitosan hydrogels before addition of EGFP, after addition, and after 1,2,3,or 4
washing steps with PBS. Washing steps are identical to those used in the real time traces.
Washing steps, where liquid on the chit-osan gel was aspirated, replaced with 20pl PBS, aspirated, and
replaced with 20pl PBS, reduced the signal from either histagged proteins or IgG after 2 minutes as
shown in Figure 26. Each washing step was presumed to eliminate nonspecific binding of proteins.
Figure 26: Percentage drops in near-IR signal 2 minutes after washing hydrogels 1,2,3, or 4 times after addition and 10
minute incubation with histagged proteins (left) or igG(right).
6. Discussion
A substantial amount of the quenching observed for the SWNT/cPVA and SWNT/CMPD
constructs does not depend on Protein A. One possible source of nonspecific interaction
between the antibody and the SWNT/polymer construct could be electrostatic forces. The
dominant subcomponents of the pooled human lgG are IgGi and lgG2, which have
isoelectric point (pl) values of 8.6+.4 and 7.4+.6 respectively (Hamilton 2001). Therefore,
we expect the human lgG to be positively charged at the neutral pH of experimental
conditions. Polyclonal mouse IgG has been reported to possess a pl of 5.5-8 (Hamilton RG
1987). The Mouse IgG would therefore be more of a mix of positive and negatively charged
antibodies. At a neutral pH all the polymers are expected to be negatively charged before
attachment of protein A, and even more negatively charged after that, because the
recombinant Invitrogen protein A has a pl value of 5.2. Based on this reasoning, it seems
unlikely that the driving interaction is electrostatic, since the mouse IgG should have less
affinity for the more negative surface than the human IgG, but it has more for both the
SWNT/cPVA and SWNT/CMPD.
In the case of human IgG the addition of protein A to SWNT/cPVA or SWNT/CMPD does not
significantly alter the response. However, for the mouse IgG there is significantly more
quenching in both cases. There is evidence from the native gel that the tested proteins do bind
to protein A, so it is not likely that most of the protein A is conjugated to the polymer and not
interacting with IgG, even if the EDC/NHS chemistry has oriented some of the protein A so that
they are sterically inhibited. The photoluminescence spectra offer evidence that the
attachment of protein A did take place. There could be something special about the mouse IgG
that allows signal transduction to happen after binding. One possible difference between the
antibodies is hinge length, since a longer hinge could allow the antigen binding regions of the
antibody to wobble around more and interact more frequently with the nanotube. However,
the literature shows that human IgG1 and mouse IgG have very similar hinge lengths, so this is
an unlikely explanation (Jeffrey L.Dangl 1988).
The SWNT/chitosan hydrogels system currently shows transient signals in control experiments
that were not expected based on other work in the Strano lab. Washing appears to return all
signals to a baseline level, suggesting that no stable binding to the NTA/Ni is taking place.
There may be an unresolved problem with the gel synthesis because there does not appear to
be more histagged EGFP retained on hydrogels with NTA/Ni versus just NTA. Transient signal is
caused by IgG when added to a hydrogel previously treated with histagged protein A, histagged
EGFP, or no other protein. There is also a large response to YPD (about 40%), and a smaller
response to BSA (about 7%) from a gel with histagged Protein A. A separate remarkable result
is that histagged EGFP was found to cause a large increase fluorescence but is reported to cause
a large decrease in fluorescence in Jin-Ho et al.
In order to critically evaluate the transient signals in the real time traces from the chitosan
hydrogels, reaction and diffusion time constants can be calculated. The binding interaction of
Protein A and IgG has a Kd of about 10nM, with a kon of 2*10s M~ s and a koff of .002 s- (Wells
1996). Assuming no rebinding, this means that the half-life for the complex is about 6 minutes
(tl/2= ln(2)/koff) and the reaction takes 25 seconds to reach 99% of equilibrium at typical
antibody concentrations (t=5/(kon*[lgG]+koff)). Therefore, incubation times of 5 minutes are
generally sufficient for specific interaction in an idealized sensor to be observed. Figure 27
shows times till 99% of equilibrium is reached for a range of IgG concentrations, and it can be
used to suggest minimum times for experimental runs. It is clear that IgG and protein A
reaction is not responsible for observed increases in fluorescence, because even at
concentrations of 6nM IgG in Figure 23, where the reaction equilibrium takes >1500s to be
established, the response curve levels off in after about 100s.
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Figure 27: Time to complete 99% of Protein A-IgG formation after additions of various amounts of IgG. Assumes that
[IgG]>>[Protein A]
There is relatively little information on the kinetics of hexahistidine-Ni/NTA binding, although
the Kd has been estimated as 14nM for a free hexahistdine sequence(Steven Knecht 2008).
However, another group reported a hexahistidine tag Kd of 700nM, possibly due to a lowered
kon because of steric hindrance(Nieba L 1997). There may be highly significant rebinding in the
hydrogel system, given the close proximity of the Ni/NTA groups. With the uncertainty
regarding the kinetics of the hexahistidine-Ni/NTA interaction, the probable rebinding, and a
Kd~100nM, it seems reasonable to suppose that the kinetics are roughly similar to that of IgG
and protein A. Histagged protein was used at a concentration of 500mg/L (11pIM), so the
reaction is expected to proceed quickly.
The other time constant of interest pertains to diffusion. Diffusivity of Ni in water is 1.2*10-5
cm2/s, while it was measured to be between .03*10-5 and .04*10-5 cm2/s in lwt% chitosan
solutions cross-linked with glutaraldehyde weight percentages of 0.1%, 0.5%, or 1% (Krajewska
2001). The diffusivity of the particular proteins used here (EGFP, protein A, igG) have not been
studied in chitosan cross-linked with glutaraldehyde. However, the diffusivities of various small
molecules and PEGs are available to suggest values for these proteins, and are presented in
Table 1. In the PEG study no diffusion of PEG 4000 through the gel was detected.
Table 1: Diffusivity and sizes of Nickel and PEG. Diffusivity was measured in a 1wt% chitosan
gel cross-linked with 0.1% glutaraldehyde. Data from (Olech 1996; Krajewska 2001)
Molecule Diffusivity (10-5 cm2/s) Radius (Angstroms)
Ni 0.03 4
PEG 400 0.07 7
PEG 600 0.02 8
PEG 1000 0.009 9
PEG 2000 0.0006 11
The chitosan/SWNT gel was measured to be approximately 0.1mm in thickness, is cross-linked
with 0.28% glutaraldehyde and has 0.69wt% chitosan. Using the diffusivity from table 1, an
estimated time constant for Nickel diffusion is to.1mm ~ L2/D = (.Ocm) 2/(.03*10-5cm2/s) = 300s.
In experiments, nickel quenching of near infrared fluorescence occurs completely in about 10s.
As can be seen in Table 2, the diffusion coefficients of the proteins of interest in water are
approximately the same as the diffusion coefficient of nickel in the hydrogel. In the hydrogel,
the diffusion coefficients of the proteins will obviously be significantly smaller. If the diffusivity
of PEG 2000 is taken as a generous upper limit on the diffusivity of all the proteins (the
molecular weight of all the proteins is an order of magnitude higher than PEG 2000) in the
chitosan gel, to.1mm = 17,000s. However, there is a near-IR response to these proteins within 10s
of addition, which generally increases for approximately ~100s before leveling off. Given that
the diffusivity of all of these proteins is probably significantly lower than that of PEG 2000, and
that there is some observed response in a time 3 orders of magnitude faster than the calculated
tO.1mm, it seems unlikely that diffusion is responsible for the observed signals. There may be
large cracks in the gels such that the true pore size is much different than expected with the
given chitosan and glutaraldehyde concentrations, or the observed fluorescence changes may
be taking place only very close to the interface between the gel and the solution.
Table 2: Diffusivity in water and size of proteins used with the chitosan/SWNT hydrogel.
Sources: a-(Flygare 1971) b-(Ank valstar 2000) c-(Ingemar Bjork 1972) d-(J.K. Armstrong 2004) e-(Hasemann CA 1989) f-
(Gilbert L 2006)
Protein Diffusivity in water (10-s cm2/s) Radius(Angstroms)
BSA 0.06a 34b
Protein A 0.04c 50c
IgG 0.04 53e
EGFP 0.12f 20f
There are several studies which have examined diffusion controlled drug release from chitosan
scaffolds cross-linked with glutaraldehyde. 5-fluorouracil was encapsulated in 2wt% chitosan
fibers through a wet spinning technique where the drug and chitosan solution was extruded
into a solution containing 0.25%, 0.5% or 1% glutaraldehyde. Release rates of .01mg 5-
fluorouracil /g chitosan/hr were observed for about 4 days after the initial burst release for all
glutaraldehyde concentrations. In a separate study, chitosan microspheres containing the small
molecule drug theophylline were synthesized by adding glutaraldehyde at a final concentration
of 0.3 to 1.6% to an emulsion of 2.7wt% chitosan and theophylline dispersed in a continuous
phase of sunflower oil. These microspheres released theophylline at about 5% of encapsulated
drug/hr after burst release (Ida Genta 1998). Another study created chitosan sponges 1mm in
height with embedded platelet derived growth factor by freeze-drying without any crosslinking,
and showed pore sizes of 100pm and protein release over many days (Yoon Jeong Park 2000).
Although building a quantitative hypothesis from these studies and other literature as to how
quickly nickel and proteins will diffuse through the SWNT/chitosan gel synthesized here is
difficult, given the different weights of chitosan and different synthesis procedures, these
studies do inform expectations. Specifically, the time scale of hours to days for diffusion of
small molecule drugs and a protein out of chitosan constructs suggests that the responses in
the SWNT/chitosan gel from nickel, in about 10s, and proteins, completing in about 100s, may
be due to observation of an interface reaction, or to an unexpectedly cracked or porous gel.
Chitosan hydrogels and their applications are reviewed by Berger et al. (J. Berger 2004). The
major parameter controlling release of a drug from a hydrogel, and therefore diffusion into the
gel as well, is crosslinking density. Logically, the greater the degree of cross-linking the smaller
the pore size, due to physical restrictions on previously separate polymer chains. This also
means less hydrogel swelling, because amino groups which would otherwise hydrogen bond
with water are removed. The pH dependence of swelling seen in some chitosan gels is thought
to depend on the protonation of these amino groups, causing chain repulsion. Ionic strength
also effects swelling by shielding charges. In a fully cross-linked chitosan gel without amino
groups, pH and ionic strength are not major drivers of hydrogel swelling(J. Berger 2004). The
chitosan used here was 80% deacetylated, making the molar ratio of amino groups to
glutaraldehyde 1:0.93, and since glutaraldehyde reacts with two amino groups almost all of the
amino groups will be cross-linked. Partial cross-linking, or electrostatic interactions of the
hydroxyl groups present on each chitosan monomer, do leave open the possibility that the
proteins are causing a change in hydrogel structure through changing the local pH or ionic
strength through diffusion of smaller species, which then alters the quenching of the SWNT.
The diffusivity of buffer ions is very close to that of Ni in the chitosan hydrogel (Krajewska
2001), while hydrogen ions may be able to move significantly faster (Sudipto K. De 2002),
making diffusion time constants for ionic and pH mediated effects roughly consistent with the
time scales of quenching observed in Figure 20-24.
As an alternative to using values of diffusion coefficients found in literature, there are several
theoretical frameworks which have been employed to model diffusive transport in hydrogels,
and they are reviewed by Amsden and Li et al. (Amsden 1998; Metters 2006). These could be
employed to estimate the diffusion coefficients of species in the synthesized gels. Diffusion of
molecules is described by Fick's second law:
dCA d2 CA
dt dr2
This one-dimensional version of the law states that the rate of change of the concentration, CA,
is proportional to concentration profile in the x-direction by the diffusion coefficient D. Given
initial conditions and a value for D, this equation can be solved to give the concentration as a
function of space and time.
Several theories have tackled the challenge of finding D. Free volume theory imagines that
solute diffuses through a polymer by jumping into voids temporarily created by thermal motion
of the polymer and solvent. Mathematically, the diffusivity in the gel, Dg, is the diffusivity at
infinite dilution, Do, adjusted by the probability Po that the solute finds an opening between the
polymer chains and a term expressing the likelihood of a free volume being created:
b= Po exp
B is a proportionality constant, a* is the cross section of the solute molecule, vf," is the free
volume per molecule of water, and is the volume fraction of polymer in the gel. Many
functional forms of Po and variations of this formula have been proposed.
Hydrodynamic theory treats the solute as a sphere whose movement is impeded by frictional
drag created by the no-slip boundary conditions at the stationary polymer strands. A model
advanced by Cukier relates the frictional drag to the adjusted diffusivity as
D exp 3LVA rST: 1/2
HMf n(L/2rj) I
Where Le is the length of the polymer chain, Mf is the molecular weight of the polymer, r, is the
radius of the solute, and rf is the radius of the polymer.
Obstruction theories assume the diffusive path length is increased by impenetrable polymer
strands. A model defines M as the average radius of opening between straight randomly
oriented polymer fibers and expresses the adjusted diffusivity as
R = exP F--f
Theoretically, movement of molecules into or out of hydrogels can be swelling controlled or
diffusion controlled. Drug release from a swelling controlled system has been modeled with
curve-fitting parameters for polymer relaxation and drug diffusion (Metters 2006). It has also
been modeled with simultaneous equations for diffusion and polymer dissolution with diffusion
coefficients dependent on the degree of water influx (J. Siepmann 2002).
7. Conclusion
The goal of my research was to design and synthesize a SWNT/polymer-protein A complex to
optically report antibody binding via a change in near infrared fluorescent emission. The idea
behind the design was that the specificity of the sensor would be conferred by the naturally
high affinity interaction between protein A and the Fc region of an antibody. However, the
polymers used to suspend SWNT showed significant responses to antibodies in the absence of
protein A and to generic proteins such as BSA. This is problematic because without a specific
high affinity interaction of the SWNT construct with the antibody, and a minimal response to
other molecules, it is difficult to envision how a single type of molecule could be recognized in a
fermentation, which is a rich soup of lipids, sugars, proteins, and ions.
In the chitosan hydrogel system the time scale of the fluorescence responses are somewhat fast
compared to the time scale for nickel to diffuse into the gel expected from literature. For
protein A, EGFP, IgG of all the species tested, and BSA, the observed responses seem to be
orders of magnitude faster than can be explained by diffusion of the proteins into the bulk of
the gel. Responses at low concentrations of IgG also show that there is a response that cannot
be due to IgG and Protein A binding. The observed responses may be due to interactions taking
place at the interface of the gel and the solution. Alternatively, there may be large defects in
the gel or there may be diffusion of a smaller species with higher mobility than the proteins,
such as buffer ions or protons, which could change the water, chitosan, and ions participating in
quenching SWNT photoluminescence.
Future research on constructing a SWNT/polymer-protein A sensor could proceed by searching
for a polymer which wraps SWNT and prevents nonspecific interactions which modulate
nanotube fluorescence. This would theoretically allow for a specific response only to antibody
binding protein A, given that attachment of protein A onto the polymer is possible and that
signal transduction takes place once the antibody binds to the protein A. A possible candidate,
not previously investigated by the Strano group, is Pluronic 103, which was shown to prevent
nonspecific binding on SWNT by using a quartz crystal microbalance (Robert J. Chen 2003).
Pluronics are triblock copolymers made of poly(ethylene oxide) and poly(propylene oxide)
which are hypothesized to create a very hydrophilic, charge-neutral surface, which blocks
nonspecific hydrophobic and electrostatic interactions.
More work toward understanding the mechanism of fluorescence response in the chitosan
hydrogel would be interesting. Scanning electron microscopy images, or an alternative
characterization of pore size, and work on immobilization of histagged EGFP exclusively in the
presence of NTA/Ni would be particularly useful. Hydrogels provide an attractive way to
immobilize SWNT in sensing applications, but solutes may alter the pH in the gel, ionic strength
in the gel, or the overall gel swelling, which may have a complicating effect on SWNT
fluorescence independent of more direct solute interaction with the SWNT. Sensors dependent
on pH or ionic strength are unlikely to be useful with cell based systems, where these variables
will be significantly affected by normal cell metabolism and not only the addition of a specific
solute. However, they may still be useful in more controlled conditions.
8. Supplementary Matlab code
%chitosanHydrogelRealtimeGraph.m: outputs data like Figure 20 with points
%colored for addition and washing
%Set f,washframes,additionframes,and SECONDSPERFRAME before running
close all;
SECONDSPERFRAME=10;
washframes =[57 58 59];
additionframes = [25 26 87 881;
reads = zeros (1000,1);
for filenum=1:1000
f = ['C: \Users\pbojo\Desktop\MEng\8211 chitosan chip\run9 ',
num2str(filenum), '.txt'];
try
[wavelength r) = textread(f, '%f %f');
catch
break;
end
reads(filenum) = r(find(wavelength==996.238));
end
reads(filenum:end)=[];
nonwashreads = reads; nonwashreads(washframes) = [];
nonwashreadframes = 1: filenum-1; nonwashreadframes(washframes) -[];
washreads = reads(washframes);
additionreads = reads (additionframes);
plot(nonwashreadframes*SECONDSPERFRAME/60.0,nonwashreads, 'o');
hold on;
plot(washframes*SECONDSPERFRAME/60.0,washreads,'go');
plot(additionframes*SECONDSPERFRAME/60.0, additionreads, 'ro');
xlabel('Minutes'); ylabel('Intensity count');
timageHistograms.m: outputs median fluorescence of an image
%set numrows,numcols before running
numrows = 5;
numcols = 4;
for row=l:numrows
for col=l:numcols
I = imread(['C:\Users\pbojo\Desktop\MEng\egfp
flourescence3\8 22 11 eglptestwithni\',num2str(row), '',
num2str(col),'.tif'];
fprintf(' d\n',median(median(I)));
end
end
%equilibriumData.m: generates average flourescence quenching and standard
%deviation data, used for graphs such as Figure12
close ail;
%VARIABLES TO SET BEFORE RUNNING SCRIPT
totalrows=3;
totalcols=4;
ratioindex=100; %10 is 997nm.
%%t% % zr %t%%
controlwavelength = zeros(totalrows*totalcols,512);
controlintensity = zeros(totalrows*totalcols,512);
wavelength =zeros (total rows* total col s, 512);
intensity = zeros (totalrows*totalcols,512);
for rows=l:totalrows
for cols=l:totalcols
f = ['C:\Users\pbojo\Desktop\MEng\cPVA SWNT ProteinA data\more
data control\', num2str (rows) , ',num2str (cols) , ' l. txt'
f2 = ['C:\Users\pbojo\Desktop\MEng\cPVA SWNT ProteinA data\more
data 24hr after\',num2str(rows),' ',num2str(cols),' 1.txt']
[controlwavelength(totalcols* (rows-1)+cols,:)
controlintensity(totalcols* (rows-1)+cols,:)] = textread(f, 'f .1f');
[ wavelength(totalcols*(rows-1)+cols,:)
intensity(totalcols* (rows-1)+cols,:)] textread(f2, '%f -f'
end
end
shifts=[]; %the percentage shifts after antibody addition
for rows=l:totalrows
for cols=1:totalcols
shifts(end+l)=((intensity(totalcols*(rows-i)+cols,ratioindex))-
controlintensity(totalcols* (rows-1)+cols,ratioindex))...
/max(controlintensity(totalcols*(rows-
1)+cols,ratioindex))*100;
end
end
?PRINT AVERAGE SHIFTS
for cols=1:totalcols
indexes = cols:totalcols:totalcols*3;
if size(indexes,2)==0
break;
end
fprintf(' Ilf n',mean(shifts(indexes)));
end
%PRINT STANDARD DEVIATIONS (variance of error in control and sample
(measurement add)
fprintf('\nPrinting Standard deviations\n');
controlindexes = 1:totalcols:totalcols*3;
for cols=1:totalcols
indexes = cols:totalcols:totalcols*3;
if size(indexes,2)==0
break;
end
fprintf(' .lf1%\n',sqrt( var(shifts(indexes))+var(shifts(controlindexes))
en;
end
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